| Authors: |
Hyams C; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.; Academic Respiratory Unit, University of Bristol, UK., Challen R; Engineering Mathematics, University of Bristol, UK., Begier E; Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, Ireland., Southern J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., King J; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK., Morley A; Academic Respiratory Unit, University of Bristol, UK., Szasz-Benczur Z; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Gonzalez MG; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Kinney J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Gray S; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Oliver J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Hubler R; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Valluri S; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Vyse A; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., McLaughlin JM; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Ellsbury G; Vaccines Medical Affairs, Pfizer Ltd, Tadworth KT20 7NS, UK., Maskell NA; Academic Respiratory Unit, University of Bristol, UK., Gessner BD; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Danon L; Engineering Mathematics, University of Bristol, UK., Finn A; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK. |